Compare · EW vs NTIC
EW vs NTIC
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and Northern Technologies International Corporation (NTIC): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while NTIC operates in Industrials - the two are in different parts of the market.
- EW is the larger of the two at $50.78B, about 693.6x NTIC ($73.2M).
- Over the past year, EW is up 15.0% and NTIC is up 4.3% - EW leads by 10.7 points.
- EW has hit the wire 5 times in the past 4 weeks while NTIC has been quiet.
- EW has more recent analyst coverage (25 ratings vs 0 for NTIC).
- Company
- Edwards Lifesciences Corporation
- Northern Technologies International Corporation
- Price
- -
- -
- Market cap
- $50.78B
- $73.2M
- 1M return
- -1.84%
- -0.51%
- 1Y return
- +15.02%
- +4.28%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 5
- 0
- Recent ratings
- 25
- 0
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Northern Technologies International Corporation
Northern Technologies International Corporation develops and markets rust and corrosion inhibiting products and services in North America, South America, Europe, Asia, the Middle East and internationally. It offers rust and corrosion inhibiting products, such as plastic and paper packaging, liquids, coatings, rust removers, cleaners, diffusers, and engineered solutions designed for the oil and gas industry under the ZERUST brand. The company also provides a portfolio of biobased and certified compostable polymer resin compounds and finished products under the Natur-Tec brand. In addition, it offers on-site and technical consulting for rust and corrosion prevention issues. The company sells its products and services to automotive, electronics, electrical, mechanical, military, retail consumer, and oil and gas markets through direct sales force, network of independent distributors and agents, manufacturer's sales representatives, strategic partners, and joint venture. Northern Technologies International Corporation was founded in 1970 and is headquartered in Circle Pines, Minnesota.
Latest EW
- SEC Form 4 filed by Edwards Lifesciences Corporation
- Barclays initiated coverage on Edwards Lifesciences with a new price target
- Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
- Edwards Lifesciences to Host Investor Event in Conjunction With TCT
- Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
- SVP, Corporate Controller Dahl Andrew M. covered exercise/tax liability with 253 shares, decreasing direct ownership by 2% to 14,615 units (SEC Form 4) to satisfy withholding tax
- CVP, JAPAC Markowitz Wayne covered exercise/tax liability with 923 shares, decreasing direct ownership by 5% to 19,371 units (SEC Form 4) to satisfy tax liability
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $54,169 worth of shares (619 units at $87.51) as part of a pre-agreed trading plan (SEC Form 4)
- CVP, TMTT, Surgical & IHFM Chopra Daveen covered exercise/tax liability with 398 shares, decreasing direct ownership by 0.90% to 43,926 units (SEC Form 4) to satisfy tax liability
- Edwards Lifesciences Comments on TAVR National Coverage Decision
Latest NTIC
- Northern Technologies International Corporation filed SEC Form 8-K: Leadership Update
- President and CEO Ramdas Gautam was granted 43,805 shares, increasing direct ownership by 58% to 118,932 units (SEC Form 4)
- New insider Ramdas Gautam claimed ownership of 75,127 shares (SEC Form 3)
- New insider Haglund Brian James claimed ownership of 1,589 shares (SEC Form 3)
- Northern Technologies International Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Northern Technologies International Corporation Announces New President and CEO and Other Key Leadership Appointments
- SEC Form 4 filed by President and CEO Lynch G Patrick
- SEC Form 4 filed by CFO and Corporate Secretary Wolsfeld Matthew C
- Director Nigon Richard was granted 7,426 shares, increasing direct ownership by 16% to 54,574 units (SEC Form 4)
- Director Lee Sunggyu was granted 6,188 shares, increasing direct ownership by 186% to 9,507 units (SEC Form 4)